[Effect and istribution of methotrexate in the human organism during leukemia treatment].
D000293:Adolescent; D000328:Adult; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007938:Leukemia / Q000188:drug therapy* / Q000378:metabolism; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000201:enzymology; D007951:Leukemia, Myeloid / Q000188:drug therapy / Q000201:enzymology; D007962:Leukocytes / Q000187:drug effects / Q000201:enzymology* / Q000378:metabolism; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000494:pharmacology / Q000652:urine; D008875:Middle Aged; D013762:Tetrahydrofolate Dehydrogenase / Q000097:blood*; D013937:Thymidine Kinase / Q000097:blood*
D013762:Tetrahydrofolate Dehydrogenase; D013937:Thymidine Kinase; D008727:Methotrexate
Wirkung und Verteilung von Methotrexat im menschlichen Organismus bei der Leukämiebehandlung.